Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
May 3, 2011Radiofrequency ablation catheter designed to treat a variety of arrhythmias
Boston Scientific Corporation (NYSE: BSX) today announced CE Mark approval and first use in Europe of its Blazer™ Open-Irrigated Catheter, the...
-
May 2, 2011
Boston Scientific Corporation (NYSE: BSX) today announced its schedule of major events and sponsored research at the 32nd Annual Scientific Sessions of...
-
Apr 27, 2011
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Bank of America Merrill Lynch 2011 Health Care Conference on May 11 in...
-
Apr 26, 2011
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Deutsche Bank 36th Annual Healthcare Conference on May 2 in Boston. Ray...
-
Apr 25, 2011Innovative alloy designed to improve new coronary stent's acute performance
Boston Scientific Corporation (NYSE: BSX) today announced U.S. Food and Drug Administration (FDA) approval and launch of the ION™ Paclitaxel-Eluting...
-
Apr 20, 2011
Boston Scientific Corporation (NYSE: BSX) today announced financial results for the first quarter ended March 31, 2011, as well as net sales and...
-
Apr 14, 2011
Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results for the first quarter ended March 31, 2011 on...
-
Apr 5, 2011Innovative stent designed to treat peripheral vascular lesions for stenoses in arteries above the knee
Boston Scientific Corporation (NYSE: BSX) today announced the start of patient enrollment in the SuperNOVA clinical trial, an international,...
-
Apr 4, 2011Reduction of geographic miss and bail-out stenting observed with highly visible PROMUS Element Stent
Boston Scientific Corporation (NYSE: BSX) today announced 12-month results from the pivotal PLATINUM Workhorse trial comparing the...
-
Apr 3, 2011Lower event rates for new alloy and stent design versus older drug-eluting stent model
Boston Scientific Corporation (NYSE: BSX) today announced results from a pooled patient-level analysis of its PERSEUS and TAXUS ATLAS...